Today: 29 April 2026
Browse Category

NASDAQ:FDS 22 November 2025

SPY Stock Forecast 2025: Outlook, Price Targets and Key Risks Into Year‑End

SPY Stock Forecast 2025: Outlook, Price Targets and Key Risks Into Year‑End

SPDR S&P 500 ETF Trust (SPY) traded near $659 on November 22, 2025, just below its all-time high after gaining low- to mid-teens percent year-to-date. Investors have withdrawn record sums despite strong performance, shifting to cheaper funds. The top 10 holdings, led by Nvidia, Apple, and Microsoft, now make up nearly 40% of the index. SPY’s forward P/E is about 23.9×, above its historical average.
22 November 2025
···

Stock Market Today

  • John Hancock Multifactor Small Cap ETF (JHSC) Sees Unusual Volume Spike
    April 29, 2026, 1:20 PM EDT. The John Hancock Multifactor Small Cap ETF (JHSC) experienced an unusual surge in trading volume Wednesday afternoon, with over 732,000 shares changing hands versus its typical three-month average of 27,000. Despite heightened activity, JHSC shares dipped 0.8% on the day. Key components driving volume included Mara Holdings, which fell 6.3% on a hefty 16.8 million shares traded, and Transocean, down 0.4% on 12.4 million shares. Vita Coco led gains within the ETF, surging 20.4%, while Siteone Landscape Supply struggled, shedding 17.2%. The wide swings among key holdings highlight the mixed sentiment within this small-cap multifactor ETF.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Go toTop